Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 1999

View Archived Issues

In vitro and in vivo testing shows chondrogenic effects for TAK-778

Company Profile: IntroGene

Micro Therapeutics treats first aneurysm patient with ONYX

CytRx completes patient enrollment in phase III pivotal study of Flocor

Vion to commence phase I trial of VNP-20009

Candidate stroke treatment advances to phase I at Shire

Disappointing results reported from phase III lisofylline trial

NuChem's anticancer drug candidates to be featured at upcoming oncology meeting

Chiron to supply meningitis C vaccine to U.K.'s NHS

Cabergoline: new use in restless legs syndrome

Celgene discovers new class of compounds inhibiting inflammatory cytokine production

New PKC inhibitors in development at AstraZeneca

Metabotropic glutamate receptor ligands from Pfizer useful for neurological, psychiatric disorders

Modulators of PTPases and their use described by Novo Nordisk

Merck's new fibrinogen receptor antagonists disclosed in recent patent

Risedronate featured in JAMA; Sweden issues first approval for osteoporosis

New bronchial therapeutics in the Byk Gulden pipeline

A total of six dementia-related proteins accepted by Bayer from Myriad Genetics

Hemosol reacquires all rights to oxygen therapeutic

Funds from NIST to be used to advance Reprogenesis's lead product into clinic

Marked and progressive bone anabolic effects found for SDZ-PTH-893 in OVX rats

Ariflo is a promising new treatment for COPD

Further SAR studies on phenyloxazolidinones reported at ICAAC by Pharmacia & Upjohn

Clinical pharmacokinetic and safety data reported for anti-HIV calanolide compound

Treatment with Tamiflu reduces secondary complications of influenza and need for antibiotics

L-084: a new oral carbapenem with good safety, favorable pharmacokinetics in humans

Urodilatin: a novel treatment approach for patients with moderate to severe asthma

MS-8209 found to be most potent known antiscrapie agent; results presented at ICAAC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...